Holen Sie sich die Stockscreener-App
5.15
3.41%
0.17
Handel nachbörslich:
5.15
Schlusskurs vom Vortag:
$4.98
Offen:
$4.94
24-Stunden-Volumen:
73,775
Relative Volume:
0.73
Marktkapitalisierung:
$256.82M
Einnahmen:
$15.33M
Nettoeinkommen (Verlust:
$-40.19M
KGV:
-2.9392
EPS:
-1.7522
Netto-Cashflow:
-
1W Leistung:
+0.78%
1M Leistung:
+22.62%
6M Leistung:
-9.65%
1J Leistung:
+2.79%
1-Tages-Spanne:
$4.86
$5.17
1-Wochen-Bereich:
$4.80
$5.30
52-Wochen-Spanne:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Firmenname
Trisalus Life Sciences Inc
Sektor
Branche
Telefon
415 336 8917
Adresse
6272 WEST 91ST AVENUE, WESTMINSTER
Vergleichen Sie TLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
5.15 | 257.32M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Eingeleitet | ROTH MKM | Buy |
| 2024-10-25 | Eingeleitet | Northland Capital | Outperform |
| 2024-09-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-30 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Trisalus Life Sciences Inc Aktie (TLSI) Neueste Nachrichten
Will a bounce in TriSalus Life Sciences Inc. Equity Warrant offer an exitTrade Exit Report & Weekly High Conviction Trade Ideas - Newser
What does recent volatility data suggest for TriSalus Life Sciences Inc.Portfolio Gains Report & Daily Stock Trend Reports - Newser
Will TriSalus Life Sciences Inc. bounce back from current supportMarket Performance Summary & Low Risk High Win Rate Stock Picks - Newser
How to build a custom watchlist for TriSalus Life Sciences Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - Newser
Will TriSalus Life Sciences Inc. stock go up soonJuly 2025 Reactions & Weekly Hot Stock Watchlists - Newser
Comparing TriSalus Life Sciences Inc. Equity Warrant in custom built stock radarsPortfolio Growth Summary & Community Shared Stock Ideas - Newser
Technical analysis overview for TriSalus Life Sciences Inc. stockWeekly Loss Report & Safe Capital Growth Tips - Newser
Candlestick signals on TriSalus Life Sciences Inc. Equity Warrant stock todayQuarterly Portfolio Report & Consistent Growth Stock Picks - Newser
Risk adjusted return profile for TriSalus Life Sciences Inc. analyzedJuly 2025 Big Picture & Weekly Top Gainers Alerts - Newser
What the charts say about TriSalus Life Sciences Inc. todayJuly 2025 Macro Moves & Capital Protection Trading Alerts - Newser
Published on: 2025-09-03 02:39:11 - Newser
Is TriSalus Life Sciences Inc. Equity Warrant meeting your algorithmic filter criteriaJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - Newser
Key resistance and support levels for TriSalus Life Sciences Inc.Entry Point & Daily Oversold Bounce Ideas - Newser
Does TriSalus Life Sciences Inc. outperform in volatile marketsJuly 2025 Analyst Calls & Safe Entry Point Identification - khodrobank.com
Combining price and volume data for TriSalus Life Sciences Inc. Equity Warrant2025 Top Gainers & Verified Entry Point Signals - Newser
Does TriSalus Life Sciences Inc. have pricing powerWeekly Investment Summary & Community Consensus Picks - khodrobank.com
Visual analytics tools that track TriSalus Life Sciences Inc. performance2025 Bull vs Bear & Safe Swing Trade Setups - Newser
How to integrate TriSalus Life Sciences Inc. into portfolio analysis toolsQuarterly Portfolio Report & Low Volatility Stock Recommendations - Newser
Real time pattern detection on TriSalus Life Sciences Inc. Equity Warrant stockWeekly Risk Summary & Scalable Portfolio Growth Methods - Newser
Is TriSalus Life Sciences Inc. Equity Warrant undervalued by DCF analysisJuly 2025 Levels & Real-Time Stock Price Movement Reports - khodrobank.com
Reversal indicators forming on TriSalus Life Sciences Inc. Equity Warrant stockDip Buying & Technical Confirmation Trade Alerts - Newser
Should I invest in TriSalus Life Sciences Inc. before earningsQuarterly Trade Summary & Low Risk Profit Maximizing Plans - khodrobank.com
Custom watchlist performance reports with TriSalus Life Sciences Inc.Options Play & Low Volatility Stock Recommendations - Newser
Is TriSalus Life Sciences Inc. part of any ETF2025 Sector Review & Daily Growth Stock Tips - khodrobank.com
How TriSalus Life Sciences Inc. stock performs during market volatilityOil Prices & Capital Protection Trade Alerts - Newser
How to track smart money flows in TriSalus Life Sciences Inc.Weekly Gains Summary & Risk Managed Trade Strategies - Newser
Is TriSalus Life Sciences Inc. a cyclical or defensive stock2025 Valuation Update & Precise Trade Entry Recommendations - khodrobank.com
What the charts say about Credit Acceptance Corporation todayJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Uveal Melanoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Novartis, Foghorn Therapeutics Inc., TriSalus Life Sciences, Inc., AstraZeneca - The Globe and Mail
Predicting TriSalus Life Sciences Inc. trend using moving averagesPortfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Trapped Investors in TriSalus Life Sciences Inc. Await Breakout Signal getLinesFromResByArray error: size == 0 - thegnnews.com
Comparing TriSalus Life Sciences Inc. in custom built stock radarsStock Surge & Free High Accuracy Swing Entry Alerts - Newser
Detecting price anomalies in TriSalus Life Sciences Inc. with AI2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.July 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Weekly Trades: Can TriSalus Life Sciences Inc. Equity Warrant navigate macro headwinds2025 Key Lessons & Weekly Momentum Picks - khodrobank.com
Can swing trading help recover from TriSalus Life Sciences Inc. losses2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Is TriSalus Life Sciences Inc. Equity Warrant currently under institutional pressure2025 Key Highlights & Smart Swing Trading Techniques - khodrobank.com
Can TriSalus Life Sciences Inc. be recession proofJuly 2025 Setups & Growth Oriented Trade Recommendations - khodrobank.com
Analyzing TriSalus Life Sciences Inc. with risk reward ratio charts2025 Price Targets & High Accuracy Trade Alerts - Newser
Key resistance and support levels for TriSalus Life Sciences Inc. Equity Warrant2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
What’s next for HCA Healthcare Inc. stock priceStock Surge & Scalable Portfolio Growth Ideas - Newser
Published on: 2025-08-31 15:12:23 - Newser
Ranking High Roller Technologies Inc. among high performing stocks via toolsWeekly Risk Report & AI Forecasted Entry and Exit Points - Newser
Forecasting TriSalus Life Sciences Inc. Equity Warrant price range with options dataTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
What technical models suggest about TriSalus Life Sciences Inc.’s comebackGlobal Markets & Daily Price Action Insights - Newser
Finanzdaten der Trisalus Life Sciences Inc-Aktie (TLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Trisalus Life Sciences Inc-Aktie (TLSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):